GL1X · GenesisL1 explorer

Research workbench

FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-DIMETHOXYBENZYL)OXY) pyrimidin-2-YL)AMINO)-3-FLUOROPHENYL)ACRYLAMIDE

Analyse FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-DIMETHOXYBENZYL)OXY)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6NVJ
Type
protein
Length
270 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fibroblast growth factor receptor 4
EC
2.7.10.1
UniProt
P22455
Ligands
XL5, SO4
Pockets
2 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFibroblast growth factor receptor 4 (EC 2.7.10.1)protein27040% helix, 16% strandP22455

Ligands and binding sites

  • XL5 · N-[2-({5-[(2,6-dichloro-3,5-dimethoxyphenyl) methoxy]pyrimidin-2-yl}amino)-3-fluorophenyl]propanamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11960.600.8125XL5
2950.340.7422empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6NVJ · FGFR4 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3… · the same entry in another collection · chain A against A, TM-score 1.00
  • P22455 · AlphaFold monomer V2.0 prediction for fibroblast growth factor receptor 4 (P22455) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.